AUTL Stock Price Chart
AUTL Price
Autolus Therapeutics PLC
$1.57
-2.48%
$-0.04
At close: May 08, 16:00:00 GMT-4
$1.63
3.82%
$0.05
Post-market: May 08, 20:00:00 GMT-4
Back
Autolus Therapeutics PLC (AUTL) Price
Key Stats
Prev.Close
$1.61
Open
$1.62
Day's Range
$1.55 - $1.63
52 week range
$1.15 - $2.7
Volume
1.1M
Avg.Volume
1.8M
Dividend yield
--
EPS (TTM)
-1.80
Market Cap
$433.8M
What is AUTL?
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. The company is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. The company has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
